Choosing an in vitro diagnostic supplier is not the same as purchasing an ordinary medical consumable. An IVD product produces information that may be used for screening, detection, diagnosis, or health monitoring. Intended use, analytical performance, labeling, storage, stability, and regulatory status are therefore central purchasing issues.
A large catalog does not prove that every assay is suitable for a distributor’s market. Each test should be evaluated by analyte, sample type, method, format, intended user, performance evidence, storage requirements, and registration pathway.
Start with the Intended Use
Two products that detect the same analyte may be designed for different environments. One may be intended for a professional laboratory, another for point-of-care use, and another may be registered for self-testing in a specific country.
Before requesting a quotation, define:
The target analyte or condition
The intended user
The testing environment
The approved sample type
Qualitative or quantitative output
Manual or reader-based format
Required result time
The destination country
The applicable regulatory pathway
This prevents the purchasing team from comparing products that share a similar name but have different intended uses.
Core Documents an IVD Supplier Should Provide
| Document | What the Buyer Should Review |
|---|
| Product specification | Analyte, method, format, components, package quantity, and model |
| Instructions for use | Intended use, user, specimen, procedure, interpretation, warnings, and limitations |
| Performance evaluation | Sensitivity, specificity, precision, cut-off, comparison method, and study population where applicable |
| Interference and cross-reactivity | Known substances or conditions that may affect results |
| Stability data | Shelf life, storage, transport, and open-pouch limitations |
| Quality documents | Quality-system and manufacturing information applicable to the assay |
| Registration documents | Evidence applying to the exact assay, format, and destination market |
An ivd reagents wholesale supplier should not use one sensitivity or specificity statement for an entire test category. Performance values must be connected to the exact assay.
Compare the Complete Test Format
Rapid tests may be supplied as strips, cassettes, cards, cups, or multi-panel devices. Laboratory reagent kits may require analyzers, calibrators, controls, or additional processing equipment.
Buyers should ask:
Does the kit include the specimen-collection material?
Are buffer and controls included?
Does the assay require a reader?
How many tests are included in one kit?
Which accessories must be purchased separately?
What training is required for the intended user?
Storage, Shipping, and Shelf Life
IVD logistics may be more demanding than the transport of standard consumables. Temperature exposure, humidity, pouch integrity, reagent stability, and remaining shelf life can affect product performance.
The buyer should confirm:
Approved storage range
Required transport conditions
Acceptable temperature excursions
Minimum remaining shelf life at shipment
Desiccant and pouch requirements
Batch and expiration traceability
Procedure for damaged or temperature-exposed goods
Audit Product-Specific Manufacturing Controls
A supplier audit should connect quality-system procedures to the exact assay being purchased. Useful audit topics include incoming-material control, environmental conditions, calibration, lot release, stability monitoring, complaint handling, change control, and recall procedures.
For example, a drug test manufacturer should be able to explain how cut-off levels, specimen types, membranes, antibodies, controls, and multi-panel configurations are managed across production lots.
Likewise, a malaria rapid test kits manufacturer should provide product-specific information about the target antigen, sample type, format, performance study, storage, and registration rather than only a general catalog description.
OEM and Private-Label IVD Programs
Private labeling an IVD product involves more than replacing the logo. Product name, intended use, claims, instructions, warnings, symbols, importer details, language, and registration-holder information may all be regulated.
Before artwork begins, the parties should agree on:
The exact assay and format
The target market
The legal manufacturer and brand owner
The registration pathway
Labeling and IFU responsibilities
Permitted performance claims
Change-control responsibilities
Minimum order quantity and production schedule
Questions for the Final Supplier Review
Which documents apply to the exact catalog number?
How are raw-material and process changes controlled?
How is lot release documented?
What happens when a stability result falls outside expectations?
How are complaints, field actions, and recalls managed?
Can the product tolerate the intended shipping route?
Who is responsible for destination-market registration?
Conclusion
A strong IVD sourcing decision begins with intended use and ends with product-level evidence. The analyte, specimen, format, user, performance data, storage, labeling, quality controls, and market registration should all be reviewed before price becomes the deciding factor.
Frequently Asked Questions
What are in vitro diagnostic reagents?
They are reagents and related products used to examine specimens taken from the human body and provide information for screening, detection, diagnosis, or monitoring.
What is the difference between an IVD reagent and a test kit?
A reagent may be one component of a testing process. A test kit generally combines the materials, device, accessories, and instructions needed for a defined assay.
How should a distributor evaluate an IVD supplier?
Review the intended use, sample type, format, performance data, IFU, stability, quality controls, labeling, registration, traceability, and change-control procedures.
Can IVD products be private labeled?
Selected products may support private labeling, but claims, artwork, IFU, legal-manufacturer information, registration, and responsibilities must be defined first.
References
U.S. Food and Drug Administration. Overview of IVD regulation. Available at: https://www.fda.gov/medical-devices/ivd-regulatory-assistance/overview-ivd-regulation.
World Health Organization. Prequalification of in vitro diagnostics. Available at: https://extranet.who.int/prequal/vitro-diagnostics.
European Parliament and Council. Regulation (EU) 2017/746 on in vitro diagnostic medical devices. Available at: https://eur-lex.europa.eu/eli/reg/2017/746/oj/eng.
